ConductScience.org, home

Paper33464409

The role of the glutamine transporter ASCT2 in antineoplastic therapy.

Teixeira E and 2 others. Cancer Chemother Pharmacol, 2021. Cited by 41 papers, by iCite.

Cite this record

ConductScience Library. The role of the glutamine transporter ASCT2 in antineoplastic therapy. Papers, record 33464409. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33464409

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The role of the glutamine transporter ASCT2 in antineoplastic therapy.
PubMed
Journal
Cancer Chemother Pharmacol
PubMed
Year
2021
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
41
iCite
Relative citation ratio, by iCite
2.24
iCite
Revised in PubMed
2021-08-24
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Teixeira EEstefânia
2Silva CCláudia
3Martel FFátimahttps://orcid.org/0000-0002-0525-3416

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Amino Acid Transport System ASCMajor topic
GlutamineMajor topic
NeoplasmsMajor topic
Animals
Antibodies, Monoclonal
Humans
Minor Histocompatibility Antigens
Oxidative Stress

Source PubMed

Download CSV of topics

References91

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127386546Fundamentals of cancer metabolism.Sci Adv2016https://conductscience.org/library/papers/27386546PubMed
231819178ASCT2 (SLC1A5)-dependent glutamine uptake is involved in the progression of head and neck squamous cell carcinoma.Br J Cancer2020https://conductscience.org/library/papers/31819178PubMed
328704361From Krebs to clinic: glutamine metabolism to cancer therapy.Nat Rev Cancer2016https://conductscience.org/library/papers/28704361PubMed
423999442Glutamine and cancer: cell biology, physiology, and clinical opportunities.J Clin Invest2013https://conductscience.org/library/papers/23999442PubMed
526054373Glutaminolysis and autophagy in cancer.Autophagy2015https://conductscience.org/library/papers/26054373PubMed
625855379Amino Acid transporters in cancer and their relevance to "glutamine addiction": novel targets for the design of a new class of anticancer drugs.Cancer Res2015https://conductscience.org/library/papers/25855379PubMed
731981058Amino Acid Transporters and Exchangers from the SLC1A Family: Structure, Mechanism and Roles in Physiology and Cancer.Neurochem Res2020https://conductscience.org/library/papers/31981058PubMed
831709772Anti-tumor effects of an antagonistic mAb against the ASCT2 amino acid transporter on KRAS-mutated human colorectal cancer cells.Cancer Med2020https://conductscience.org/library/papers/31709772PubMed
931535081Critical role of ASCT2-mediated amino acid metabolism in promoting leukaemia development and progression.Nat Metab2019https://conductscience.org/library/papers/31535081PubMed
1030210919An anti-ASCT2 monoclonal antibody suppresses gastric cancer growth by inducing oxidative stress and antibody dependent cellular toxicity in preclinical models.Am J Cancer Res2018https://conductscience.org/library/papers/30210919PubMed
1127865832Establishment of monoclonal antibodies against cell surface domains of ASCT2/SLC1A5 and their inhibition of glutamine-dependent tumor cell growth.Biochem Biophys Res Commun2017https://conductscience.org/library/papers/27865832PubMed
124768607Amino acid metabolism and its disorders.Major Probl Clin Pediatr1973https://conductscience.org/library/papers/4768607PubMed
1326590711Cancer's Fuel Choice: New Flavors for a Picky Eater.Mol Cell2015https://conductscience.org/library/papers/26590711PubMed
144715268Testicular feminization.Indian J Med Sci1973https://conductscience.org/library/papers/4715268PubMed
1528441384Hopefully devoted to Q: targeting glutamine addiction in cancer.Br J Cancer2017https://conductscience.org/library/papers/28441384PubMed
1631100352Therapeutic targeting of glutaminolysis as an essential strategy to combat cancer.Semin Cell Dev Biol2020https://conductscience.org/library/papers/31100352PubMed
1726791262Metabolic reprogramming in cancer cells: glycolysis, glutaminolysis, and Bcl-2 proteins as novel therapeutic targets for cancer.World J Surg Oncol2016https://conductscience.org/library/papers/26791262PubMed
1825628363Regulation of mammalian nucleotide metabolism and biosynthesis.Nucleic Acids Res2015https://conductscience.org/library/papers/25628363PubMed
1920832749Targeting mitochondrial glutaminase activity inhibits oncogenic transformation.Cancer Cell2010https://conductscience.org/library/papers/20832749PubMed
2021555572Pyruvate carboxylase is required for glutamine-independent growth of tumor cells.Proc Natl Acad Sci U S A2011https://conductscience.org/library/papers/21555572PubMed

See all 91 referencesDownload CSV of references

Cited by28

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 41 citations.

PMIDTitleJournalYearIn PapersSource
42745749Metabolic reprogramming-related drug resistance in osteosarcoma: from molecular mechanisms to therapeutic translation.Front Mol Biosci2026https://conductscience.org/library/papers/42745749PubMed
42733724Japanese encephalitis virus reprograms host pyrimidine metabolism to facilitate viral replication.Infect Med (Beijing)2026https://conductscience.org/library/papers/42733724PubMed
42519728Research progress in metabolic reprogramming and targeting metabolic pathways for clear cell renal cell carcinoma.Genes Dis2026https://conductscience.org/library/papers/42519728PubMed
42435173Epigenetics and One-Carbon Metabolism in Cancer: Mechanisms and Therapeutic Implications.Adv Exp Med Biol2026https://conductscience.org/library/papers/42435173PubMed
41898313Targeting the Glutamine Transporter SLC1A5 Enhances Sensitivity of Acute Myeloid Leukemia to MLN4924.Biomedicines2026https://conductscience.org/library/papers/41898313PubMed
40374895Yuanhuacine suppresses head and neck cancer growth by promoting ASCT2 degradation and inhibiting glutamine uptake.Acta Pharmacol Sin2025https://conductscience.org/library/papers/40374895PubMed
39844410Targeting Glutamine Metabolic Reprogramming in Pancreatic Cancer: Current Insights and Future Directions.Curr Cancer Drug Targets2026https://conductscience.org/library/papers/39844410PubMed
39308523Glutamine transporters as effective targets in digestive system malignant tumor treatment.Oncol Res2024https://conductscience.org/library/papers/39308523PubMed
39215845Glutamine and leukemia research: progress and clinical prospects.Discov Oncol2024https://conductscience.org/library/papers/39215845PubMed
39090116Emerging mechanisms and promising approaches in pancreatic cancer metabolism.Cell Death Dis2024https://conductscience.org/library/papers/39090116PubMed
38972133Therapeutic implications of the metabolic changes associated with BRAF inhibition in melanoma.Cancer Treat Rev2024https://conductscience.org/library/papers/38972133PubMed
38844930Elevated SLC1A5 associated with poor prognosis and therapeutic resistance to transarterial chemoembolization in hepatocellular carcinoma.J Transl Med2024https://conductscience.org/library/papers/38844930PubMed
38670587Deregulated circRNAs in Epithelial Ovarian Cancer With Activity in Preclinical In Vivo Models: Identification of Targets and New Modalities for Therapeutic Intervention.Cancer Genomics Proteomics2024https://conductscience.org/library/papers/38670587PubMed
38571483Babaodan overcomes cisplatin resistance in cholangiocarcinoma via inhibiting YAP1.Pharm Biol2024https://conductscience.org/library/papers/38571483PubMed
38432394Baicalein induces apoptosis by inhibiting the glutamine-mTOR metabolic pathway in lung cancer.J Adv Res2025https://conductscience.org/library/papers/38432394PubMed
38400818CircCPA4 induces ASCT2 expression to promote tumor property of non-small cell lung cancer cells in a miR-145-5p-dependent manner.Thorac Cancer2024https://conductscience.org/library/papers/38400818PubMed
37928274Glutamine metabolism controls amphiregulin-facilitated chemoresistance to cisplatin in human chondrosarcoma.Int J Biol Sci2023https://conductscience.org/library/papers/37928274PubMed
37718764Bioinformatic Analysis of The Prognostic Value of A Panel of Six Amino Acid Transporters in Human Cancers.Cell J2023https://conductscience.org/library/papers/37718764PubMed
37655270Lobetyolin inhibits cell proliferation and induces cell apoptosis by downregulating ASCT2 in gastric cancer.Cytotechnology2023https://conductscience.org/library/papers/37655270PubMed
37298344Impact of Solute Carrier Transporters in Glioma Pathology: A Comprehensive Review.Int J Mol Sci2023https://conductscience.org/library/papers/37298344PubMed

See all 28 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
SLC1A56510PubTator's text mininghttps://conductscience.org/library/genes/6510

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33464409

GET https://conductscience.org/api/papers/v1/33464409/references?page=2